A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN2)

A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors

Hemophilia
Hemophilia A

Results
Download
Print

Study results

LPS_BH29992_HAVEN 2_final results_Mar2021_African_South Africa (PDF, 1.2 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_French_France (PDF, 1.3 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_German (PDF, 0.6 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Japanese (PDF, 2.3 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Sotho_South Africa (PDF, 1.2 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Spanish_LATAM (PDF, 0.7 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Spanish_Spain (PDF, 0.7 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Turkish (PDF, 1.1 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Zulu_South Africa (PDF, 1.2 MB)

LPS BH29992 HAVEN 2 Final Results March 2023 English (PDF, 1.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN2)

Study results

LPS_BH29992_HAVEN 2_final results_Mar2021_African_South Africa (PDF, 1.2 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_French_France (PDF, 1.3 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_German (PDF, 0.6 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Japanese (PDF, 2.3 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Sotho_South Africa (PDF, 1.2 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Spanish_LATAM (PDF, 0.7 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Spanish_Spain (PDF, 0.7 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Turkish (PDF, 1.1 MB)

LPS_BH29992_HAVEN 2_final results_Mar2021_Zulu_South Africa (PDF, 1.2 MB)

LPS BH29992 HAVEN 2 Final Results March 2023 English (PDF, 1.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN2)

For the latest version of this information please go to www.forpatients.roche.com